Pfizer (PFE) Completes Tender Offer for Shares of Encysive Pharmaceuticals (ENCY)

April 15, 2008 8:28 AM EDT

Pfizer Inc (NYSE: PFE) announced that the subsequent offering period of the tender offer by its wholly-owned subsidiary, Explorer Acquisition Corp., to purchase all of the outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ: ENCY) at a purchase price of $2.35 per share, net to the seller in cash, without interest thereon and less any required withholding taxes, expired as of 5:00 p.m., New York City time, on April 14, 2008. According to the final report of the depositary for the tender offer, as of the expiration of the subsequent offering period, 69,076,466 shares, representing approximately 85.33% of the outstanding shares of Encysive common stock, were validly tendered and purchased pursuant to the offer. [JT]

Sign up at EasyStockAlerts.com & Make Money Today!


Related Categories

Corporate News
Mergers and Acquisitions

Stocks Mentioned

ENCY 2.35

+0.00 +0.00%
Volume: 0
Track ENCY

PFE 18.61

+0.44 +2.42%
Volume: 21,054,866
Track PFE


Add Your Comment